Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Sibbing

Showing results (21-30 of 200) with videos related to

Pageof 20
Sort By:
JACC. Cardiovascular Interventions|September 21, 2019
Reply: Platelet Function and Genetic Testing in Patients Receiving Oral Anticoagulation and Antiplatelet Treatment: An Area of Unmet NeedDirk Sibbing, Dominick J Angiolillo
JACC. Cardiovascular Interventions|December 7, 2019
Reply: Therapeutic Window of P2Y<sub>12</sub> Inhibition: Should the Current Limits Be Modified?Dirk Sibbing, Dominick J Angiolillo
Journal of Clinical Medicine|September 18, 2020
De-Escalation of Antiplatelet Treatment in Patients with Myocardial Infarction Who Underwent Percutaneous Coronary Intervention: A Review of the Current LiteratureDaniel Mf Claassens, Dirk Sibbing
Journal of the American College of Cardiology|February 27, 2016
CYP2C19 in ACS Patients: Could Genotyping Have a Role in Medically Managed Patients or Beyond?Dirk Sibbing, Lisa Gross, Steffen Massberg
Thrombosis and Haemostasis|September 4, 2015
Prevention of cardiovascular events with antiplatelet treatment: does time of intake matter for aspirin and ADP receptor blockers?Dirk Sibbing, Lisa Gross, Dániel Aradi
Seminars in Thrombosis and Hemostasis|February 18, 2016
Platelet Function Testing in Patients on Antiplatelet MedicationsLisa Gross, Dániel Aradi, Dirk Sibbing
International Journal of Cardiology|January 8, 2013
Current evidence for monitoring platelet reactivity in acute coronary syndrome: a plea for individualized antiplatelet treatmentDaniel Aradi, Dirk Sibbing, Laurent Bonello
JAMA|October 4, 2012
Influence of smoking on treatment with clopidogrelDirk Sibbing, Willibald Hochholzer, Adnan Kastrati
Internal and Emergency Medicine|April 9, 2024
De-escalation of antithrombotic treatment after acute coronary syndrome, a new paradigmAndrea Rubboli, Dan Atar, Dirk Sibbing
European Heart Journal|December 30, 2015
Pre-treatment with P2Y12 inhibitors in ACS patients: who, when, why, and which agent?Dirk Sibbing, Adnan Kastrati, Peter B Berger
Pageof 20

Showing results (21-30 of 200) with videos related to

Sort By:
Pageof 20
JACC. Cardiovascular Interventions|September 21, 2019
Reply: Platelet Function and Genetic Testing in Patients Receiving Oral Anticoagulation and Antiplatelet Treatment: An Area of Unmet NeedDirk Sibbing, Dominick J Angiolillo
JACC. Cardiovascular Interventions|December 7, 2019
Reply: Therapeutic Window of P2Y<sub>12</sub> Inhibition: Should the Current Limits Be Modified?Dirk Sibbing, Dominick J Angiolillo
Journal of Clinical Medicine|September 18, 2020
De-Escalation of Antiplatelet Treatment in Patients with Myocardial Infarction Who Underwent Percutaneous Coronary Intervention: A Review of the Current LiteratureDaniel Mf Claassens, Dirk Sibbing
Journal of the American College of Cardiology|February 27, 2016
CYP2C19 in ACS Patients: Could Genotyping Have a Role in Medically Managed Patients or Beyond?Dirk Sibbing, Lisa Gross, Steffen Massberg
Thrombosis and Haemostasis|September 4, 2015
Prevention of cardiovascular events with antiplatelet treatment: does time of intake matter for aspirin and ADP receptor blockers?Dirk Sibbing, Lisa Gross, Dániel Aradi
Seminars in Thrombosis and Hemostasis|February 18, 2016
Platelet Function Testing in Patients on Antiplatelet MedicationsLisa Gross, Dániel Aradi, Dirk Sibbing
International Journal of Cardiology|January 8, 2013
Current evidence for monitoring platelet reactivity in acute coronary syndrome: a plea for individualized antiplatelet treatmentDaniel Aradi, Dirk Sibbing, Laurent Bonello
JAMA|October 4, 2012
Influence of smoking on treatment with clopidogrelDirk Sibbing, Willibald Hochholzer, Adnan Kastrati
Internal and Emergency Medicine|April 9, 2024
De-escalation of antithrombotic treatment after acute coronary syndrome, a new paradigmAndrea Rubboli, Dan Atar, Dirk Sibbing
European Heart Journal|December 30, 2015
Pre-treatment with P2Y12 inhibitors in ACS patients: who, when, why, and which agent?Dirk Sibbing, Adnan Kastrati, Peter B Berger
Pageof 20